tradingkey.logo
搜尋

Artivion Inc

AORT
添加自選
22.770USD
-0.170-0.74%
收盤 05/15, 16:00美東報價延遲15分鐘
1.11B總市值
88.74本益比TTM

Artivion Inc

22.770
-0.170-0.74%

關於 Artivion Inc 公司

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc簡介

公司代碼AORT
公司名稱Artivion Inc
上市日期Feb 12, 1993
CEOMackin (James Patrick)
員工數量1600
證券類型Ordinary Share
年結日Feb 12
公司地址1655 Roberts Boulevard N W
城市KENNESAW
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編30144
電話17704193355
網址https://artivion.com/
公司代碼AORT
上市日期Feb 12, 1993
CEOMackin (James Patrick)

Artivion Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
--
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
--
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
--
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
--
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
--
Dr. Marshall S. Stanton, M.D.
Dr. Marshall S. Stanton, M.D.
Senior Vice President, Clinical Research and Chief Medical Officer
Senior Vice President, Clinical Research and Chief Medical Officer
39.13K
+34.61%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-27.61%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
203.01K
+7.32%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
167.55K
+10.84%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
--
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
--
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
134.82K
+4.40%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
--

收入明細

單位: USD更新時間: 4月6日 週一
單位: USD更新時間: 4月6日 週一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
業務USD
名稱
營收
佔比
Aortic stent grafts
159.37M
36.11%
On X
101.74M
23.05%
Preservation Services
95.50M
21.64%
Bio Glue
76.60M
17.36%
Surgical sealants
76.60M
17.36%
Other
8.11M
1.84%
地區USD
名稱
營收
佔比
International
227.25M
51.49%
United States
214.07M
48.51%
業務
地區
業務USD
名稱
營收
佔比
Aortic stent grafts
159.37M
36.11%
On X
101.74M
23.05%
Preservation Services
95.50M
21.64%
Bio Glue
76.60M
17.36%
Surgical sealants
76.60M
17.36%
Other
8.11M
1.84%

股東統計

更新時間: 5月10日 週日
更新時間: 5月10日 週日
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.17%
Nomura Investment Management Business Trust
5.38%
Fidelity Management & Research Company LLC
4.98%
Vanguard Capital Management, LLC
4.02%
Morgan Stanley Smith Barney LLC
3.78%
其他
69.67%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
12.17%
Nomura Investment Management Business Trust
5.38%
Fidelity Management & Research Company LLC
4.98%
Vanguard Capital Management, LLC
4.02%
Morgan Stanley Smith Barney LLC
3.78%
其他
69.67%
股東類型
持股股東
佔比
Investment Advisor
50.56%
Investment Advisor/Hedge Fund
32.13%
Individual Investor
4.67%
Hedge Fund
4.36%
Private Equity
3.55%
Research Firm
1.49%
Pension Fund
1.01%
Bank and Trust
0.42%
Venture Capital
0.03%
其他
1.76%

機構持股

更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
449
45.29M
93.40%
+501.67K
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
5.91M
12.33%
+292.30K
+5.21%
Dec 31, 2025
Nomura Investment Management Business Trust
2.61M
5.46%
+129.63K
+5.22%
Dec 31, 2025
Fidelity Management & Research Company LLC
2.42M
5.05%
-420.69K
-14.81%
Dec 31, 2025
Morgan Stanley Smith Barney LLC
1.83M
3.83%
-32.21K
-1.73%
Dec 31, 2025
Perceptive Advisors LLC
1.72M
3.6%
-297.71K
-14.74%
Dec 31, 2025
State Street Investment Management (US)
1.58M
3.31%
+44.64K
+2.90%
Dec 31, 2025
Wellington Management Company, LLP
1.41M
2.94%
-95.68K
-6.37%
Dec 31, 2025
Fred Alger Management, LLC
1.37M
2.87%
+55.32K
+4.20%
Dec 31, 2025
Juniper Investment Company, LLC
1.19M
2.48%
-144.56K
-10.84%
Dec 31, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
查看更多
AAM Sawgrass US Small Cap Quality Growth ETF
佔比4.14%
Unusual Whales Subversive Democratic Trading ETF
佔比3.4%
ROBO Global Healthcare Technology & Innovation ETF
佔比1.85%
State Street SPDR S&P Health Care Equipment ETF
佔比1.74%
Invesco S&P SmallCap Health Care ETF
佔比1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比0.69%
First Trust Small Cap Growth AlphaDEX Fund
佔比0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0.42%
iShares Micro-Cap ETF
佔比0.33%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
暫無數據
公告日期
除權除息日
類型
比率
暫無數據
KeyAI